BioCentury
ARTICLE | Clinical News

PF-00299804: Preliminary Phase II data

October 18, 2010 7:00 AM UTC

Preliminary data from the open-label, international Phase II A7471017 trial in 74 patients with previously untreated advanced NSCLC showed that once-daily PF-00299804 produced PFS rates of 78%, 73% an...